Cardiac Safety Services Market Growth & Trends
The global cardiac safety services market size is anticipated to reach USD 1,924.3 million by 2030 and is projected to grow at a CAGR of 12.1% from 2025 to 2030, according to a report by Grand View Research, Inc. This growth is driven by the alarming prevalence of cardiovascular diseases (CVDs) and significant advancements in medical technology. As per the CDC, in U.S., one person dies due to any cardiovascular disease every 33 seconds, underscoring the critical need for effective cardiac monitoring and intervention. In 2022, heart disease caused 702,880 deaths, representing one in every five deaths and highlighting the vast market potential for cardiac safety services.
Moreover, approximately 805,000 people in the U.S. experience a heart attack each year, with 605,000 being first-time incidents and 200,000 involving individuals who have previously suffered a heart attack. Expanding clinical trials, particularly those focused on cardiovascular diseases or involving therapies with potential cardiovascular impacts, drives the demand for cardiac safety services. As pharmaceutical and biopharmaceutical companies invest in developing new cardiovascular drugs and devices, there is an increased need for specialized cardiac safety assessments to ensure that these products do not adversely affect heart health. This growth in clinical trials, combined with the complexity of modern trials, necessitates robust and reliable cardiac safety services to support drug development and regulatory compliance.
Pharmaceutical companies, medical device manufacturers, and academic institutions continually invest in R&D to drive innovation and growth in the cardiac safety services market. Research initiatives often require sophisticated cardiac safety monitoring to support the development of new therapies and technologies. This investment fosters the development of new cardiac safety solutions and supports continuously improving existing services.
Request a free sample copy or view report summary: Cardiac Safety Services Market Report
Cardiac Safety Services Market Report Highlights
- Based on service, the ECG/Holter monitors segment led the market with the largest revenue share of 41.0% in 2024. Electrocardiogram (ECG) and Holter monitors are crucial tools for continuous cardiac monitoring, enabling real-time detection of arrhythmias, ischemic episodes, and other cardiovascular conditions
- Based on type, the integrated segment led the market with the largest revenue share of 63.0% in 2024. This prominence is primarily driven by the increasing demand for comprehensive, multi-functional cardiac monitoring solutions that offer enhanced accuracy, efficiency, and patient convenience
- Based on end use, the pharma & biopharma segment led the market with the largest revenue share of 44.0% in 2024
Access Press Release@ https://www.grandviewresearch.com/press-release/global-cardiac-safety-services-market
Cardiac Safety Services Market Segmentation
Grand View Research has segmented the global cardiac safety services market report based on service, type, end use, and region
Cardiac Safety Services Service Outlook (Revenue, USD Million, 2018 - 2030)
- ECG/Holter Monitors
- ECG Patch
- Holter Monitors
- Blood Pressure Monitors
- Aneroid Blood Pressure Monitors
- Digital Blood Pressure Monitors
- Ambulatory Blood Pressure Monitors
- Cardiovascular Imaging
- CT
- MRI
- Ultrasound
- Nuclear Medicine
- Others
Cardiac Safety Services Type Outlook (Revenue, USD Million, 2018 - 2030)
- Integrated
- Standalone
Cardiac Safety Services End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharma & Biopharma Companies
- CROs
- Others
Cardiac Safety Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players of Cardiac Safety Services Market
- Medpace
- IQVIA
- PPD Inc.,
- Charles River Laboratories
- Wuxi AppTec
- Eurofins Scientific
- Celerion
- Nova Research Laboratories
- Laboratory Corporation of America Holdings
- Koninklije Philips N.V.
- ICON Plc.
- SGS S.A.
- Clario
- Certara
- Richmond Pharmacology
- Biotrial
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment